百克生物(688276)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688276 百克生物

已收盘 01-03 15:00:00

{"stockData":{"symbol":"688276","market":"SH","secType":"STK","nameCN":"百克生物","latestPrice":23.66,"timestamp":1735887600000,"preClose":24.19,"halted":0,"volume":1722502,"delay":0,"changeRate":-0.0219,"floatShares":413999999,"shares":413999999,"eps":1.0016,"marketStatus":"已收盘","change":-0.53,"latestTime":"01-03 15:00:00","open":24.02,"high":24.36,"low":23.63,"amount":41321400,"amplitude":0.0302,"askPrice":23.69,"askSize":8,"bidPrice":23.66,"bidSize":46,"shortable":0,"etf":0,"ttmEps":1.0016,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1736127000000},"marketStatusCode":5,"adr":0,"adjPreClose":24.19,"symbolType":"stock_kcb","openAndCloseTimeList":[[1735867800000,1735875000000],[1735880400000,1735887600000]],"highLimit":26.61,"lowLimit":21.77,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":413657598,"isCdr":false,"pbRate":2.33,"roa":"--","peRate":23.622204,"roe":"5.92%","epsLYR":1.21,"committee":0.465517,"marketValue":9787000000,"turnoverRate":0.0042,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-01-06。","afterMarket":{"amount":0,"volume":0,"close":23.66,"buyVolume":0,"sellVolume":0,"time":1735889638029,"indexStatus":"已收盘 01-03 15:30:00","preClose":24.19},"floatMarketCap":9787000000},"requestUrl":"/m/hq/s/688276/tweets","defaultTab":"tweets","newsList":[{"id":"2500161166","title":"百克生物：公司鼻喷流感减毒活疫苗上市许可申请已获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2500161166","media":"同花顺iNews","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500161166?lang=zh_cn&edition=full","pubTime":"2025-01-03 16:27","pubTimestamp":1735892822,"startTime":"0","endTime":"0","summary":"同花顺金融研究中心01月03日讯，有投资者向百克生物提问， 你好，四月份提交的水剂鼻喷流感疫苗，离获批现在已经进展到什么程度了？公司回答表示，尊敬的投资者您好，截至目前，公司鼻喷流感减毒活疫苗（液体制剂）上市许可申请已获得受理，生产现场和临床试验现场检查已完毕，感谢您的关注。点击进入交易所官方互动平台查看更多","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103163623ab9cf1c3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103163623ab9cf1c3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2500643221","title":"百克生物:市场环境不好是真实原因，公司上市时并未包装过","url":"https://stock-news.laohu8.com/highlight/detail?id=2500643221","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500643221?lang=zh_cn&edition=full","pubTime":"2025-01-03 16:25","pubTimestamp":1735892700,"startTime":"0","endTime":"0","summary":"投资者提问：你好，公司老是以市场环境不好来推脱业绩下降，难道公司当初上巿的时候没有包装过？董秘回答(百克生物SH688276)：尊敬的投资者您好，感谢您的关注。查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2025-01-03/doc-inecsrnz1601969.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2500816932","title":"百克生物：公司持续专注主营业务，提升经营管理水平","url":"https://stock-news.laohu8.com/highlight/detail?id=2500816932","media":"同花顺iNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500816932?lang=zh_cn&edition=full","pubTime":"2025-01-03 16:21","pubTimestamp":1735892460,"startTime":"0","endTime":"0","summary":"同花顺金融研究中心01月03日讯，有投资者向百克生物提问， 你好，公司年初出了一个提质增效回报投资者的公告，然后就以今年股价吉林省上市公司跌幅第一来回报投资者吗？公司回答表示，尊敬的投资者您好，公司持续专注主营业务，提升经营管理水平，将以提高公司质量为基础，努力提升公司投资价值和股东回报能力。感谢您的关注。点击进入交易所官方互动平台查看更多","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103162849a213fdf9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103162849a213fdf9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2500165257","title":"百克生物01月03日主力资金流出308万元 连续3日减仓","url":"https://stock-news.laohu8.com/highlight/detail?id=2500165257","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500165257?lang=zh_cn&edition=full","pubTime":"2025-01-03 15:21","pubTimestamp":1735888870,"startTime":"0","endTime":"0","summary":"01月03日, 百克生物股价跌2.19%，报收23.66元，成交金额4132万元，换手率0.42%，振幅3.02%，量比0.98。百克生物今日主力资金净流出308万元，连续3日净流出，上一交易日主力净流出531万元，今日环比减少42.00%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为68.42%，平均跌幅为1.73%。该股近5个交易日下跌8.33%，主力资金累计净流出718万元；近20日主力资金累计净流出7302万元，其中净流出天数为16日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103154026ab9cdf96&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250103154026ab9cdf96&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2495793668","title":"12月31日百克生物创60日新低，红塔红土医药精选股票发起式A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2495793668","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495793668?lang=zh_cn&edition=full","pubTime":"2024-12-31 16:16","pubTimestamp":1735633018,"startTime":"0","endTime":"0","summary":"证券之星消息，12月31日百克生物创60日新低，收盘报25.11元，当日跌3.79%，换手率0.57%，成交量2.36万手，成交额6019.69万元。重仓百克生物的公募基金请见下表：该股最近90天内共有1家机构给出评级，买入评级1家。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共3家，其中持有数量最多的公募基金为红塔红土医药精选股票发起式A。红塔红土医药精选股票发起式A目前规模为0.11亿元，最新净值0.9992，较上一交易日上涨0.58%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024123100026946.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688276","BK1515","BK1574","BK0239","BK1161","09939","159938"],"gpt_icon":0},{"id":"2495375424","title":"一周复盘 | 百克生物本周累计下跌1.02%，生物制品板块下跌3.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495375424","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2495375424?lang=zh_cn&edition=full","pubTime":"2024-12-29 10:41","pubTimestamp":1735440094,"startTime":"0","endTime":"0","summary":"百克生物本周累计下跌1.02%，周总成交额1.9亿元，截至本周收盘，百克生物股价为26.09元。本次百克生物获批临床的冻干b型流感嗜血杆菌结合疫苗接种对象为2月龄及以上婴幼儿，接种后可刺激机体产生免疫应答，用于预防由b型流感嗜血杆菌引起的侵袭性感染。百克生物：收到《药物临床试验批准通知书》12月25日晚间，百克生物发布公告称，公司近日收到国家药品监督管理局下发的冻干b型流感嗜血杆菌结合疫苗的《药物临床试验批准通知书》。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.jrj.com.cn/2024/12/29104146919414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2494852279","title":"百克生物收盘下跌0.31%，滚动市盈率25.77倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2494852279","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494852279?lang=zh_cn&edition=full","pubTime":"2024-12-26 20:26","pubTimestamp":1735215999,"startTime":"0","endTime":"0","summary":"12月26日，百克生物今日收盘25.81元，下跌0.31%，滚动市盈率PE达到25.77倍。从行业市盈率排名来看，公司所处的生物制品行业市盈率平均35.01倍，行业中值36.44倍，百克生物排名第40位。股东方面，截至2024年9月30日，百克生物股东户数10466户，较上次减少662户，户均持股市值35.28万元，户均持股数量2.76万股。公司被持续认定为国家级“高新技术企业”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226203328985027fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241226203328985027fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2494404277","title":"百克生物收盘下跌0.92%，滚动市盈率25.85倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2494404277","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494404277?lang=zh_cn&edition=full","pubTime":"2024-12-25 20:26","pubTimestamp":1735129618,"startTime":"0","endTime":"0","summary":"12月25日，百克生物今日收盘25.89元，下跌0.92%，滚动市盈率PE达到25.85倍。从行业市盈率排名来看，公司所处的生物制品行业市盈率平均35.13倍，行业中值36.51倍，百克生物排名第40位。消息面上，百克生物12月12日接待中信建投等2家机构调研，上市公司接待人员包括董事会秘书张喆。公司被持续认定为国家级“高新技术企业”。最新一期业绩显示，2024年三季报，公司实现营业收入10.26亿元，同比-17.47%；净利润2.44亿元，同比-26.19%，销售毛利率85.50%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225203132984ecfd8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241225203132984ecfd8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2494045394","title":"【长春高新：控股子公司冻干b型流感嗜血杆菌结合疫苗临床试验申请获批准】金融界12月25日消息，近日，长春高新技术产业（集团）股份有限公司控股子公司长春百克生物科技股份公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，冻干b型流感嗜血杆菌结合疫苗的临床试验申请获得批准。该疫苗接种对象为2月龄及以上婴幼儿，采用特定工艺制备，有利于保证产品质量和提高稳定性。如临床试验进展顺利，将利于公司拓宽业务结构等。但由于医药产品特点，本次临床试验进程存在不确定性。公司将积极推进项目并及时披露进展情况。","url":"https://stock-news.laohu8.com/highlight/detail?id=2494045394","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494045394?lang=zh_cn&edition=full","pubTime":"2024-12-25 18:34","pubTimestamp":1735122848,"startTime":"0","endTime":"0","summary":"金融界12月25日消息，近日，长春高新技术产业（集团）股份有限公司控股子公司长春百克生物科技股份公司收到国家药品监督管理局核准签发的《药物临床试验批准通知书》，冻干b型流感嗜血杆菌结合疫苗的临床试验申请获得批准。该疫苗接种对象为2月龄及以上婴幼儿，采用特定工艺制备，有利于保证产品质量和提高稳定性。如临床试验进展顺利，将利于公司拓宽业务结构等。但由于医药产品特点，本次临床试验进程存在不确定性。公司将积极推进项目并及时披露进展情况。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/25183446804613.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["159646","BK0028","BK0239","159938","BK0188","BK1583","BK1576","BK0057","BK1161","BK0046","000661","BK1574","BK0075","09939","BK1141","03347","688276","BK1515"],"gpt_icon":0},{"id":"2494016601","title":"百克生物(688276.SH)：冻干b型流感嗜血杆菌结合疫苗临床试验申请获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2494016601","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2494016601?lang=zh_cn&edition=full","pubTime":"2024-12-25 15:35","pubTimestamp":1735112132,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百克生物 发布公告，公司近日收到国家药品监督管理局下发的冻干b型流感嗜血杆菌结合疫苗的《药物临床试验批准通知书》。研究显示，在Hi造成的严重疾病中，约95%是由b型流感嗜血杆菌引起。本次公司获批临床的冻干b型流感嗜血杆菌结合疫苗接种对象为2月龄及以上婴幼儿，接种后可刺激机体产生免疫应答，用于预防由b型流感嗜血杆菌引起的侵袭性感染。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1229327.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159646","BK0239","BK1583","BK1141","03347","688276","BK1576"],"gpt_icon":0},{"id":"2493754699","title":"百克生物收盘下跌2.12%，滚动市盈率25.76倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2493754699","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2493754699?lang=zh_cn&edition=full","pubTime":"2024-12-23 20:22","pubTimestamp":1734956578,"startTime":"0","endTime":"0","summary":"12月23日，百克生物今日收盘25.8元，下跌2.12%，滚动市盈率PE达到25.76倍。从行业市盈率排名来看，公司所处的生物制品行业市盈率平均35.14倍，行业中值35.66倍，百克生物排名第40位。消息面上，百克生物12月12日接待中信建投等2家机构调研，上市公司接待人员包括董事会秘书张喆。公司被持续认定为国家级“高新技术企业”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223202634a204c9b7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241223202634a204c9b7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","BK0239"],"gpt_icon":0},{"id":"2492445172","title":"百克生物收盘上涨0.69%，滚动市盈率26.32倍","url":"https://stock-news.laohu8.com/highlight/detail?id=2492445172","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492445172?lang=zh_cn&edition=full","pubTime":"2024-12-20 20:52","pubTimestamp":1734699170,"startTime":"0","endTime":"0","summary":"12月20日，百克生物今日收盘26.36元，上涨0.69%，滚动市盈率PE达到26.32倍。从行业市盈率排名来看，公司所处的生物制品行业市盈率平均35.80倍，行业中值36.44倍，百克生物排名第41位。消息面上，百克生物12月12日接待中信建投等2家机构调研，上市公司接待人员包括董事会秘书张喆。公司被持续认定为国家级“高新技术企业”。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220205734a1fdeacc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220205734a1fdeacc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2492490892","title":"百克生物：公司根据在研产品进度，有序的开展工程建设","url":"https://stock-news.laohu8.com/highlight/detail?id=2492490892","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492490892?lang=zh_cn&edition=full","pubTime":"2024-12-20 18:00","pubTimestamp":1734688835,"startTime":"0","endTime":"0","summary":"证券之星消息，百克生物(688276)12月20日在投资者关系平台上答复投资者关心的问题。投资者：您好！请问公司，现有疫苗产能有多少百克生物董秘：尊敬的投资者您好，公司根据在研产品进度，有序的开展工程建设。目前水痘-带状疱疹疫苗原液车间可满足1,600万人份/年的疫苗供应需求，冻干鼻喷流感疫苗车间可满足1,440万人份/年的疫苗供应需求；新建水痘、带状疱疹疫苗车间可满足2,000万人份/年的疫苗供应需求，能较好的满足产品市场需求，感谢您对公司的关注。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024122000032103.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"gpt_icon":0},{"id":"2492786416","title":"百克生物：疫苗原液车间可满足1,600万人份/年疫苗供应，冻干鼻喷流感疫苗车间可供应1,440万人份/年，新建疫苗车间可供应2,000万人份/年","url":"https://stock-news.laohu8.com/highlight/detail?id=2492786416","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492786416?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:27","pubTimestamp":1734683223,"startTime":"0","endTime":"0","summary":"金融界12月20日消息，有投资者在互动平台向百克生物提问：您好！请问公司，现有疫苗产能有多少。公司回答表示：公司根据在研产品进度，有序的开展工程建设。目前水痘-带状疱疹疫苗原液车间可满足1,600万人份/年的疫苗供应需求，冻干鼻喷流感疫苗车间可满足1,440万人份/年的疫苗供应需求；新建水痘、带状疱疹疫苗车间可满足2,000万人份/年的疫苗供应需求，能较好的满足产品市场需求。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220185426ab86d05f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220185426ab86d05f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","688276","BK0239"],"gpt_icon":0},{"id":"2492499747","title":"百克生物mRNA疫苗临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2492499747","media":"财中社","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492499747?lang=zh_cn&edition=full","pubTime":"2024-12-20 16:25","pubTimestamp":1734683100,"startTime":"0","endTime":"0","summary":"财中社12月20日电百克生物 发布关于其Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获得批准的公告。此次临床试验的疫苗名为LVRNA101，与珠海丽凡达生物技术有限公司联合申报。该疫苗为多组分疫苗，能够同时诱导体液免疫应答和细胞免疫应答，利用mRNA技术增强免疫应答，提升了疫苗成功开发的可能性。公司表示，若该疫苗顺利完成临床试验并获批上市，将有助于优化产品结构和增强长期盈利能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220165353ab868241&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220165353ab868241&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["159646","BK0239","688276"],"gpt_icon":0},{"id":"2492746021","title":"百克生物：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2492746021","media":"界面","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492746021?lang=zh_cn&edition=full","pubTime":"2024-12-20 15:40","pubTimestamp":1734680434,"startTime":"0","endTime":"0","summary":"百克生物12月20日公告，公司近日收到国家药品监督管理局下发的《药物临床试验批准通知书》，获准公司的LVRNA101即Ⅱ型单纯疱疹病毒mRNA疫苗（即“HSV-2疫苗”）用于开展预防由Ⅱ型单纯疱疹病毒感染导致的生殖器疱疹的临床试验。本次公司获批临床的Ⅱ型单纯疱疹病毒疫苗系与珠海丽凡达生物技术有限公司联合申报（公司为批件持有人），该疫苗为多组分疫苗，能够同时诱导体液免疫应答和细胞免疫应答，且利用mRNA技术路线进一步增强细胞免疫应答，与传统的技术路线相比提高了疫苗成功开发的可能性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220154034ab865ba4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220154034ab865ba4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688276","BK0239","159646"],"gpt_icon":0},{"id":"2492601954","title":"百克生物(688276.SH)：Ⅱ型单纯疱疹病毒mRNA疫苗临床试验申请获得批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2492601954","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492601954?lang=zh_cn&edition=full","pubTime":"2024-12-20 15:39","pubTimestamp":1734680355,"startTime":"0","endTime":"0","summary":"智通财经APP讯，百克生物(688276.SH)发布公告，公司近日收到国家药品监督管理局下发的《药物临床试验批准通知书》，同意LVRNA101开展预防由Ⅱ型单纯疱疹病毒感染导致的生殖器疱疹的临床试验。本次公司获批的LVRNA101即Ⅱ型单纯疱疹病毒mRNA疫苗(即“HSV-2疫苗”)。截至目前，全球暂无相关疫苗产品成功开发上市。若公司该Ⅱ型单纯疱疹病毒mRNA疫苗能够成功开发，将进一步丰富公司产品管线，更好地满足市场需求。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1227562.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","688276","BK1576","BK1141","BK1583","03347","159646"],"gpt_icon":0},{"id":"2492946729","title":"百克生物：HSV-2疫苗临床试验申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2492946729","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2492946729?lang=zh_cn&edition=full","pubTime":"2024-12-20 15:34","pubTimestamp":1734680043,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["159646","BK0239","BK1583","BK1576","BK1141","03347","688276"],"gpt_icon":0},{"id":"2491479303","title":"百克生物：中信建投、嘉实基金等多家机构于12月12日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2491479303","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491479303?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:03","pubTimestamp":1734084194,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年12月13日百克生物发布公告称中信建投、嘉实基金于2024年12月12日调研我司。2024年，受外部环境的影响，成人疫苗接种意愿均有所下降；受降库存的影响，带状疱疹疫苗发货较上年同期有所下降，收入减少。目前公司流感疫苗价格未进行调整。其中，水痘疫苗新增出口至阿富汗；带状疱疹疫苗实现首次出口至哥伦比亚。该股最近90天内共有2家机构给出评级，买入评级2家。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300034290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0276","688276","601066"],"gpt_icon":0},{"id":"2491347378","title":"百克生物：公司如有相关计划，将及时履行信息披露义务","url":"https://stock-news.laohu8.com/highlight/detail?id=2491347378","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2491347378?lang=zh_cn&edition=full","pubTime":"2024-12-13 18:00","pubTimestamp":1734084023,"startTime":"0","endTime":"0","summary":"百克生物董秘：尊敬的投资者您好，公司严格遵守《上海证券交易所科创板股票上市规则》等相关法律法规，核心技术人员自公司股票上市之日起12个月内和离职后6个月内不得转让本公司首发前股份，感谢您的关注。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024121300034116.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","688276"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2021-06-25","address":"吉林省长春市朝阳区高新开发区火炬路1260号","stockEarnings":[{"period":"1week","weight":-0.0931},{"period":"1month","weight":-0.1024},{"period":"3month","weight":-0.2268},{"period":"6month","weight":-0.2402},{"period":"1year","weight":-0.5661},{"period":"ytd","weight":-0.0577}],"companyName":"长春百克生物科技股份公司","boardCode":"AI0027","perCapita":"39523股","boardName":"医药制造业","registeredCapital":"41365万元","compareEarnings":[{"period":"1week","weight":-0.0555},{"period":"1month","weight":-0.0455},{"period":"3month","weight":-0.0375},{"period":"6month","weight":0.0886},{"period":"1year","weight":0.087},{"period":"ytd","weight":-0.0419}],"survey":"　　长春百克生物科技股份公司的主营业务是人用疫苗的研发、生产和销售。主要产品有水痘疫苗、鼻喷流感疫苗、带状疱疹疫苗。公司被持续认定为国家级“高新技术企业”。公司被吉林省科技厅认定为高新技术企业，批准设立“吉林省疫苗科技创新中心”、被吉林省发改委批准设立“吉林省疫苗工程研究中心”、被长春国家生物产业基地认定为“长春国家生物产业基地疫苗工程研究中心”、被吉林省工信厅认定为“省级企业技术中心”。","serverTime":1736033821182,"listedPrice":36.35,"stockholders":"10466人(较上一季度减少5.95%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.4","shortVersion":"4.29.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"百克生物(688276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供百克生物(688276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"百克生物,688276,百克生物股票,百克生物股票老虎,百克生物股票老虎国际,百克生物行情,百克生物股票行情,百克生物股价,百克生物股市,百克生物股票价格,百克生物股票交易,百克生物股票购买,百克生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"百克生物(688276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供百克生物(688276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}